The Therapeutic Effects of Mifepristone on Endometriosis Compared with Danazol

In: Journal of Practical Obstetrics and Gynecology · 2002 · W2383502100
article OA: closed CC0
View on OpenAlex

Abstract

Objectives:To investigate the therapeutic effects and side effects of mifepristone on endometriosis.Methods: 90 patients suffering from endometriosis were selected and divided non-randomly into A and B groups.Group A was administered tablets of mifepristone 25 mg q.d.whereas Group B was administered tablets of Danazol 200 mg,Bid or Tid,for 6 months and followed up for 6~30 months. Results:For Group A the remission rate of symptoms was 95.6%,remission rate of physical signs was 75.6%,the pregnancy rate was 69.2%,and the recurrence rate was 31.8%. The group B was 97.5%,80%,71.4%,42.6% respectively.The differences in therapeutic effects and recurrence rate between the about groups did not have any statistic significance.The weight gain rate and abnormal rate of ALT of Group A were 6.6% and 2.2% separately,Group B was 95.6% and 42.2% respectively.The differences in the groups had obvious statistic significance.Conclusions: Mifepristone was similar to Danazol in the therapeutic effects on endomatriosis,but mifepristone has fewer side effects and was widely applied in clinical treatment.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK